Anti-Kappa Opioid Receptor 抗体 [EPR18881]
Anti-Kappa Opioid Receptor antibody [EPR18881]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal Kappa Opioid Receptor antibody. Suitable for IP, WB, IHC-P and reacts with Mouse, Rat samples. Cited in 11 publications.
別名を表示する
Kappa-type opioid receptor, K-OR-1, KOR-1, MSL-1, Oprk1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Immunohistochemical analysis of paraffin-embedded Rat spleen tissue labeling Kappa Opioid Receptor with ab183825 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Negative staining on rat spleen.
Counter stained with Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Immunohistochemical analysis of paraffin-embedded Mouse hippocampus tissue labeling Kappa Opioid Receptor with ab183825 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Mainly membrane staining on neuron cell of mouse hippocampus is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labeling Kappa Opioid Receptor with ab183825 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Negative staining on mouse spleen.
Counter stained with Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Immunohistochemical analysis of paraffin-embedded Rat hippocampus tissue labeling Kappa Opioid Receptor with ab183825 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Mainly membrane staining on neuron cells of rat hippocampus is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Kappa Opioid Receptor was immunoprecipitated from 1mg of Mouse brain whole cell lysate with ab183825 at 1/100 dilution.
Western blot was performed from the immunoprecipitate using ab183825 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : Mouse brain whole cell lysate 10μg (Input).
Lane 2 : ab183825 IP in Mouse brain whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab183825 in Mouse brain whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825)
Predicted band size: 42 kDa
false
- WB
Supplier Data
Western blot - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Blocking/Dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 20574683).
All lanes:
Western blot - Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825) at 1/1000 dilution
Lane 1:
Rat brain lysate at 10 µg
Lane 2:
Rat heart lysate at 10 µg
Lane 3:
Rat kidney lysate at 10 µg
Lane 4:
Rat spleen lysate at 10 µg
Lane 5:
C6 (Rat glial tumor cells) whole cell lysate at 10 µg
Lane 6:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 42 kDa
Observed band size: 58 kDa
false
Exposure time: 30s
- WB
Unknown
Western blot - Anti-Kappa Opioid Receptor antibody [EPR18881] (AB183825)
Blocking/Dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 20574683).
All lanes:
Western blot - Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825) at 1/1000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse heart lysate at 10 µg
Lane 3:
Mouse kidney lysate at 10 µg
Lane 4:
Mouse spleen lysate at 10 µg
Lane 5:
NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysate at 10 µg
Lane 6:
Neuro-2a (Mouse neuroblastoma cells) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 42 kDa
Observed band size: 58 kDa
false
Exposure time: 3min
関連する標識済み抗体及び組成の異なる製品 (8)
-
Anti-Kappa Opioid Receptor antibody [EPR18881] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Kappa Opioid Receptor antibody [EPR18881]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Kappa Opioid Receptor antibody [EPR18881]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Kappa Opioid Receptor antibody [EPR18881]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Kappa Opioid Receptor antibody [EPR18881]
-
660 APC
APC Anti-Kappa Opioid Receptor antibody [EPR18881]
-
578 PE
PE Anti-Kappa Opioid Receptor antibody [EPR18881]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Kappa Opioid Receptor antibody [EPR18881]
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Kappa opioid receptors mediate pain perception mood regulation and stress response. They form part of a larger receptor family the G-protein coupled receptors (GPCRs) which are critical in cellular signaling. Activation of these receptors can produce analgesic effects differing from other opioid receptors due to their unique mechanism of action. Kappa receptors interact with endogenous ligands called dynorphins which are peptide neurotransmitters involved in natural pain relief processes.
Pathways
Kappa opioid receptors are integral to the dopaminergic and serotonergic pathways. In the dopaminergic pathway kappa receptors reduce dopamine release influencing the reward system and potentially affecting addiction behaviors. In the serotonergic pathway they modulate serotonin levels connecting to mood and anxiety regulation. These pathways also involve proteins like the mu-opioid receptor and delta-opioid receptor which along with kappa receptors form a complex regulatory network.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (11)
Recent publications for all applications. Explore the full list and refine your search
Evidence-based complementary and alternative medicine : eCAM 2023:6058951 PubMed37790739
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 133: PubMed37561576
2023
Applications
Unspecified application
Species
Unspecified reactive species
Current research in neurobiology 5:100107 PubMed38020805
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107536 PubMed37636073
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC neuroscience 23:58 PubMed36217122
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 16:894886 PubMed35726232
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 17:350-366 PubMed34596819
2021
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 11:2822-2844 PubMed33456575
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 13:1392 PubMed31998063
2020
Applications
Unspecified application
Species
Unspecified reactive species
International immunopharmacology 73:23-40 PubMed31078923
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com